What top creators are saying about KSI-501(KSI-501)

Kodiak Sciences' investigational treatment for eye diseases

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about KSI-501.

Strongly bearish
avg -0.90
0 bullish0 neutral1 bearish

Top creators covering KSI-501 (KSI-501)

The 1 sources with the most insights about KSI-501 on Kazuha.

Latest insights about KSI-501 (KSI-501)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Today

Very Bearish

The treatment was criticized for failing to demonstrate an advantage over Eylea while requiring more frequent injections; the speaker anticipated another failure.

Discussed alongside KSI-501 (KSI-501)

Other assets that creators frequently mention in the same content as KSI-501.

Frequently asked

Which podcasters and creators cover KSI-501 (KSI-501) the most?

The most active sources covering KSI-501 (KSI-501) on Kazuha are @shkreliplanet. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about KSI-501 (KSI-501) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about KSI-501 (KSI-501) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside KSI-501 (KSI-501)?

Creators covering KSI-501 (KSI-501) most frequently also discuss KOD, EYLEA. See the "Discussed alongside" section above for full asset pages.